Omada Health, Inc. (OMDA) company profile

Omada Health provides virtual chronic care management that connects individuals with personalized care teams between clinical visits. Its offerings include cardiometabolic programs for diabetes prevention, weight health, diabetes, hypertension, and medication support for individuals taking GLP-1 therapies. The company also provides a musculoskeletal program connecting participants with licensed physical therapists for remote evaluation and exercise therapy. Care is delivered through digital applications supported by health coaches, clinical specialists, connected devices, and machine learning tools. Omada sells its services directly and through channel partners to employers, health plans, health systems, and pharmacy benefit managers.

As of December 31, 2025, the company had more than 2,000 customers and over 886,000 enrolled members across its programs, having supported nearly two million individuals since launch. Omada employs 916 full-time personnel under a remote-first operating model. The organization holds intellectual property in the United States and across fifteen foreign jurisdictions, and its nutrition platform references foods from over 150 countries. The provided report does not state a corporate headquarters.

Summary of the business section of Omada Health's latest annual report, written by StockData.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“The initial public offering price per share is $19.00.”

Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.